Propofol‐induced hypertriglyceridemia in critically ill trauma patients requiring nutrition therapy: A descriptive cohort study
Journal of Parenteral and Enteral Nutrition · 2026-08 · 50 (6) · 794-804
DOI: 10.1002/jpen.70105 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Parenteral and Enteral Nutrition, online erschienen am 17.05.2026. Verfasst von Emma S Lemke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Hypertriglyceridemia, Critical Illness, Propofol, Wounds and Injuries. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
This study aimed to assess the incidence and identify risk factors associated with the development of propofol‐induced hypertriglyceridemia in critically ill trauma patients who required nutrition therapy.
Methods
Adult patients (aged >17 years) admitted to the trauma intensive care unit who received propofol for >24 h and had a serum triglyceride concentration determination during the infusion were retrospectively evaluated. Hypertriglyceridemia was defined as a serum triglyceride concentration > 400 mg/dL. Potential risk factors for hypertriglyceridemia as well as linear and nonlinear correlative relationships between propofol‐associated lipid injectable emulsion dose and serum triglyceride concentration were evaluated.
Results
One hundred and ninety‐five serum triglyceride determinations were obtained from 100 patients. Twenty‐five patients (25%) developed hypertriglyceridemia. The greatest risk factor for hypertriglyceridemia was lipid injectable emulsion dose (0.48 [0.36, 0.64] vs 0.28 [0.20, 0.49] g/kg/day; P < 0.01). Those who exhibited hypertriglyceridemia had a higher C‐reactive protein ( P < 0.02), lower prealbumin ( P = 0.001), higher serum creatinine ( P < 0.04), and required more days of nutrition therapy ( P < 0.03). The hypertriglyceridemia group exhibited a nonlinear concave lipid dose–serum triglyceride concentration response relationship ( r = 0.731, P = 0.001) whereas those without hypertriglyceridemia had a flattened and variable linear relationship ( r = 0.115, P = 0.34).
Conclusion
Hypertriglyceridemia is common during propofol therapy, reflective of lipid injectable emulsion dose, and is associated with greater inflammation, organ dysfunction, and severe critical illness requiring prolonged nutrition therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
- TriStar Horizon Medical Center, Dickson, Tennessee, USA.
- St Bernard's Regional Medical Center, Jonesboro, Arkansas, USA.
- Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
ORCID-Profile: Roland N Dickerson
Zitieren
APA
Lemke, E. S., Walker, J. K., Farrar, J. E., Byerly, S., Filiberto, D. M., & Dickerson, R. N. (2026). Propofol‐induced hypertriglyceridemia in critically ill trauma patients requiring nutrition therapy: A descriptive cohort study. Journal of Parenteral and Enteral Nutrition, 50(6), 794-804. https://doi.org/10.1002/jpen.70105
Vancouver
Lemke ES, Walker JK, Farrar JE, Byerly S, Filiberto DM, Dickerson RN. Propofol‐induced hypertriglyceridemia in critically ill trauma patients requiring nutrition therapy: A descriptive cohort study. Journal of Parenteral and Enteral Nutrition. 2026;50(6):794-804. doi:10.1002/jpen.70105
BibTeX
@article{Lemke2026,
author = {Lemke, Emma S and Walker, Jonathon K and Farrar, Julie E and Byerly, Saskya and Filiberto, Dina M and Dickerson, Roland N},
title = {Propofol‐induced hypertriglyceridemia in critically ill trauma patients requiring nutrition therapy: A descriptive cohort study},
journal = {Journal of Parenteral and Enteral Nutrition},
year = {2026},
volume = {50},
number = {6},
pages = {794--804},
doi = {10.1002/jpen.70105}
}
EUVIMED